(Q47328656)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Economic evaluation of weight loss interventions in overweight and obese women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

4

Sue J Goldie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2

Karen M Kuntz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Larissa Roux

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1093-1106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

Economic costs of obesity and inactivity

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Medical hazards of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Long-term weight maintenance after an intensive weight-loss program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The Effects on Plasma Lipoproteins of a Prudent Weight-Reducing Diet, with or without Exercise, in Overweight Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Behavioral counseling in primary care to promote physical activity: recommendation and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Physical activity as a predictor of weight maintenance in previously obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The continuing epidemics of obesity and diabetes in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The natural history of the development of obesity in a cohort of young U.S. adults between 1981 and 1998

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The public health impact of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Impact of overweight on the risk of developing common chronic diseases during a 10-year period

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The disease burden associated with overweight and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Actual Causes of Death in the United States, 2000

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Body Weight and Mortality among Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Long-term maintenance of weight loss: current status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Obesity: genes, glands or gluttony?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

A multidimensional weight-management program for women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The treatment and prevention of obesity: a systematic review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Modeling for health care and other policy decisions: uses, roles, and validity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Combining behavioral and pharmacological treatments for obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Weight-loss maintenance in overweight individuals one to five years following successful completion of a commercial weight loss program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Weight loss maintenance in women two to eleven years after participating in a commercial program: a survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The prevalence of weight loss maintenance among American adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Long-term weight-loss maintenance: a meta-analysis of US studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Successful weight loss maintenance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Comparison of single versus multiple lifestyle interventions: are the antihypertensive effects of exercise training and diet-induced weight loss additive?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Lifestyle intervention in overweight individuals with a family history of diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Relation of weight loss to changes in serum lipids and lipoproteins in obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Exercise in the treatment of obesity: Effects of four interventions on body composition, resting energy expenditure, appetite, and mood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Treatment with orlistat reduces cardiovascular risk in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Weight as a risk factor for clinical diabetes in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The 25-year health care costs of women who remain overweight after 40 years of age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Lifetime Health and Economic Consequences of Obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Cost-effectiveness of diagnostic strategies for patients with chest pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Theoretical issues in cost-effectiveness analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Accounting for future costs in medical cost-effectiveness analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Obesity rising to alarming levels around the world.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Epidemic of obesity expands its spread to developing countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Estimating Health-Related Quality of Life in Obese Individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Obesity and quality of life: mediating effects of pain and comorbidities.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

A prospective study of weight change and health-related quality of life in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Lifetime health and economic benefits of weight loss among obese persons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The cost-effectiveness of a cardiovascular risk reduction program in general practice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

A cost-effectiveness analysis of exercise as a health promotion activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Patient-specific decisions about hormone replacement therapy in postmenopausal women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

The importance of patient preferences for comorbidities in cost-effectiveness analyses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

Exercise and the maintenance of weight loss: 1-year follow-up of a controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

inferred from DOI database lookup

7 January 2021

based on heuristic

Obesity: responding to the global epidemic

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.125

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2006.125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16861615%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference